Literature DB >> 6251018

Antibiotics that specifically block translation in virus-infected cells.

J C Lacal, D Vázquez, J M Fernandez-Sousa, L Carrasco.   

Abstract

Several antibiotics including anthelmycin, blasticidin S, destomycin A, gougerotin, hygromycin B and edeine complex, known to powerfully block translation in cell-free systems, did neither inhibit protein synthesis in intact mouse L and 3T6 cells, nor in hamster BHK 21 cells, due to failure to cross the cell plasma membrane. However, after viral infection, these antibiotics exhibited a marked blockade of translation, that is related to the permeability changes induced by viral infection. The inhibition of protein synthesis by hygromycin B in virus-infected cells was studied over the time course of infection, both in encephalomyocarditis virus-infected mouse L cells and in Semliki forest virus-infected hamster BHK cells. We have observed that the entry of hygromycin B into virus-infected cells parallels the inhibition of cellular protein synthesis, i.e., the cells became permeable to this antibiotic at the time the shut-off of host translation occurred. A marked inhibition of picornavirus RNA synthesis by hygromycin B was also noticed, likely as a consequence of the inhibition of the viral replicase synthesis. Finally, a reduction in the virus yield by treatment of virus-infected cells with several antibiotics is also described. All these observations are considered in the context of the interference of viral infection with cellular functions and the potential use of inhibitors non-permeable to normal cells as antiviral agents.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6251018     DOI: 10.7164/antibiotics.33.441

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  10 in total

1.  Changes in membrane permeability in cells infected by human cytomegalovirus.

Authors:  M Rugolo; B Baldassarri; M P Landini
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

2.  Myxoviruses do not induce non-specific alterations in membrane permeability early on in infection.

Authors:  K A Foster; K J Micklem; G Agnarsdottir; C L Lancashire; N N Bogomolova; Y S Boriskin; C A Pasternak
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

3.  Antiviral activity of geneticin against dengue virus.

Authors:  Xianchao G Zhang; Peter W Mason; Edward J Dubovi; Xiaodong Xu; Nigel Bourne; Randall W Renshaw; Timothy M Block; Alexander V Birk
Journal:  Antiviral Res       Date:  2009-03-11       Impact factor: 5.970

4.  Antiviral effects of hygromycin B, a translation inhibitor nonpermeant to uninfected cells.

Authors:  J C Lacal; L Carrasco
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

5.  Permeability to alpha sarcin in virus-infected cells.

Authors:  C Fernández-Puentes
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

6.  GouR, a TetR family transcriptional regulator, coordinates the biosynthesis and export of gougerotin in Streptomyces graminearus.

Authors:  Junhong Wei; Yuqing Tian; Guoqing Niu; Huarong Tan
Journal:  Appl Environ Microbiol       Date:  2013-11-15       Impact factor: 4.792

7.  The potential of nucleotide analogs as inhibitors of retroviruses and tumors.

Authors:  R K Robins
Journal:  Pharm Res       Date:  1984-01       Impact factor: 4.200

8.  Effective suppression of dengue virus using a novel group-I intron that induces apoptotic cell death upon infection through conditional expression of the Bax C-terminal domain.

Authors:  James R Carter; James H Keith; Tresa S Fraser; James L Dawson; Cheryl A Kucharski; Kate M Horne; Stephen Higgs; Malcolm J Fraser
Journal:  Virol J       Date:  2014-06-13       Impact factor: 4.099

9.  Optimization of cytotoxic activity of Nocardia sp culture broths using a design of experiments.

Authors:  Alba Noël; Gwendoline Van Soen; Isabelle Rouaud; Eric Hitti; Sophie Tomasi
Journal:  PLoS One       Date:  2020-01-14       Impact factor: 3.240

Review 10.  Picornavirus inhibitors.

Authors:  L Carrasco
Journal:  Pharmacol Ther       Date:  1994       Impact factor: 12.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.